Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Aytu Biopharma (AYTU) Interest Expenses (2016 - 2025)

Historic Interest Expenses for Aytu Biopharma (AYTU) over the last 15 years, with Q4 2025 value amounting to $560000.0.

  • Aytu Biopharma's Interest Expenses fell 4810.01% to $560000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $2.7 million, marking a year-over-year decrease of 4095.57%. This contributed to the annual value of $3.7 million for FY2025, which is 2680.37% down from last year.
  • Per Aytu Biopharma's latest filing, its Interest Expenses stood at $560000.0 for Q4 2025, which was down 4810.01% from $516000.0 recorded in Q3 2025.
  • Aytu Biopharma's Interest Expenses' 5-year high stood at $1.3 million during Q3 2023, with a 5-year trough of $516000.0 in Q3 2025.
  • In the last 3 years, Aytu Biopharma's Interest Expenses had a median value of $1.0 million in 2024 and averaged $983800.0.
  • Its Interest Expenses has fluctuated over the past 5 years, first plummeted by 1477.09% in 2024, then plummeted by 4810.01% in 2025.
  • Quarter analysis of 3 years shows Aytu Biopharma's Interest Expenses stood at $1.3 million in 2023, then decreased by 14.77% to $1.1 million in 2024, then plummeted by 48.1% to $560000.0 in 2025.
  • Its last three reported values are $560000.0 in Q4 2025, $516000.0 for Q3 2025, and $730000.0 during Q2 2025.